University of South Florida · BiochemistryNeuroCOVID Research Laboratory
Subhra Mohapatra · Tampa, Florida
Research Focus
Dr. Subhra Mohapatra's lab at the University of South Florida focuses on understanding the long-term neurological effects of COVID-19, particularly how the virus impacts tau proteins related to neurodegenerative diseases like Alzheimer's. The lab uses mouse models to investigate how aging and COVID-19 infection can lead to neurological issues, aiming to find new ways to prevent or treat these conditions. Through their research, they hope to identify specific molecular targets that can be manipulated to reduce the negative effects of COVID-19 on the brain.
neuro-COVIDtauopathyneuroinflammationCOVID-19mouse modelsFKBP51cognitive declineagingneurodegenerationdrug targeting
Research Aims
5AIM 01Investigate the impact of aging on neuroinflammation and tauopathy following COVID-19 infection in mice.
AIM 02Characterize the progression of tauopathies in transgenic mice post COVID-19 infection.
AIM 03Identify critical molecular targets contributing to cognitive decline in neuro-COVID.
AIM 04Assess the effectiveness of dendrimer-based therapies in reducing neuroinflammation and tau phosphorylation.
AIM 05Explore the link between COVID-19 infection and pre-existing neurodegenerative conditions.
Skills the Lab Values
mouse modelsimmunohistochemistryspatial transcriptomicsPCRWestern blotin vivo imagingRNA sequencingdendrimer formulationgene expression analysisbehavioral analysis
Output against the department
Publications153bottom 43% of dept.227th of 402
this lab
most publishedleast published
Citations3.9kbottom 21% of dept.319th of 402
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.